Wegovy and Period Cramps: What We Know So Far

What the trial data does (and does not) tell us about menstrual symptoms

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults on semaglutide 2.4mg for 68 weeks and reported average body weight reductions of around 15%. Menstrual changes were not a primary or secondary outcome in STEP 1, so we have no controlled data on how often period cramps changed, worsened, or improved. That absence of data is itself informative: it tells us this was not a signal large enough to become a named adverse event in the headline results, but it does not tell us the symptom is rare in the real world.

Post-marketing reports collected via the MHRA's Yellow Card scheme and equivalent international pharmacovigilance systems have included cycle irregularities among GLP-1 users, though cause and effect are difficult to establish in spontaneous reporting. What this means practically: if you experience heavier cramping after starting Wegovy, that experience is real and plausible — it just does not yet have a definitive mechanistic proof in the published literature. Our prescribers hear this question regularly.

The honest clinical position is that menstrual symptoms are likely driven by the weight-loss process itself rather than semaglutide acting directly on reproductive tissue. The speed of that weight loss (faster than most people achieve through diet alone) is probably the key variable.

How weight loss changes the hormones that govern your cycle

Body fat is hormonally active. Adipose tissue converts androgens to oestrogen via an enzyme called aromatase, so a meaningful reduction in fat mass can shift oestrogen levels relatively quickly. That hormonal shift can alter the thickness of the uterine lining that builds each cycle and, in turn, the amount and character of the cramping when it sheds. This is the same mechanism behind cycle disruption seen after bariatric surgery and during rapid calorie restriction, it is not unique to GLP-1 medicines.

Prostaglandins drive uterine muscle contractions during menstruation. Any state that heightens inflammation or changes oestrogen signalling can affect prostaglandin production. For some women, weight loss actually reduces dysmenorrhoea over time, because excess body fat is associated with higher baseline inflammation. For others, the transition period brings temporarily more intense cramps before the cycle settles. The NHS semaglutide information page does not list dysmenorrhoea as a recognised side effect, which aligns with the trial picture: it is not a pharmacological effect of the drug at the receptor level.

If you are also using oral contraceptives alongside tirzepatide (a related GLP-1 medicine), current UK guidance recommends adding a barrier method during the early weeks of treatment because gastric slowing can affect pill absorption, though this specific interaction concern applies less clearly to semaglutide. The wider question of contraception on GLP-1 treatment is covered in more detail on our page about periods and Wegovy.

Separating GI cramping from menstrual cramping

Gastrointestinal symptoms are among the most commonly reported effects of semaglutide. Nausea, abdominal discomfort, and lower-gut cramping can occur at any point in the cycle and are sometimes attributed to period pain when the timing coincidentally overlaps. This is worth bearing in mind: if cramping seems more diffuse, begins around a dose day, or is accompanied by nausea and loose stools, the source may be GI rather than uterine.

The distinction matters because the management differs. GI cramping typically settles within days to two weeks of a dose change and responds to practical measures, eating smaller amounts, avoiding high-fat meals, staying hydrated. Menstrual cramping that is genuinely new or worsening warrants a conversation with your GP or prescriber, particularly if it is affecting daily functioning. If you want to understand the full picture of how cramps can present on Wegovy, including both GI and menstrual sources, that is a useful place to start working out what is driving your symptoms.

One thing that can help you track this: keep a brief symptom diary for two or three cycles, noting when cramps occur relative to your dose day and your cycle day. That information is far more useful to a clinician than a general report of "worse cramps since starting". It is also the kind of detail that makes a follow-up review with our prescribers more productive, you can reach our support team seven days a week if symptoms feel urgent before a scheduled review.

When to seek medical advice and what to mention

Most cycle changes that appear in the first one to three months of Wegovy treatment are transient. They reflect a body adjusting to meaningful hormonal and metabolic change. But there are situations where you should not wait for a routine review.

Speak to a GP or call NHS 111 promptly if you experience: severe pelvic pain that does not follow your usual cycle pattern; bleeding that is significantly heavier than your normal period or that occurs between periods; pain accompanied by fever; or any symptom that feels qualitatively different from anything you have had before. Some people also find that leg cramps on Wegovy appear alongside other muscular symptoms during the early weeks, and our guide to semaglutide cramps can help you understand the different types you might notice and how to describe them to a clinician, so it is worth noting where any cramping is located when you report it. Reporting suspected side effects through the MHRA's Yellow Card service is also encouraged for any unexpected symptoms, including menstrual changes, since it contributes to the ongoing safety picture for medicines like Wegovy.

If you have a history of endometriosis, polycystic ovary syndrome, or other conditions affecting your cycle, mention this during your initial consultation. These conditions can interact with the hormonal shifts of rapid weight loss in ways that are worth planning for in advance, and women with irregular cycles may also find our guide on not having a period on Wegovy helpful for understanding what is and is not expected. You can explore the full range of treatment options we prescribe, and what our clinical review covers, on the weight-loss treatments page, then check your eligibility to start a free consultation with our prescribers.